Understanding Epigenetic Clocks: How Biological Age Differs From Chronological Age

Epigenetic clocks measure biological aging by tracking predictable changes in DNA methylation across the human lifespan, according to a recent scientific review published in the journal npj Aging and supplementary findings detailed in PMC. Researchers analyzing data from the Health and Retirement Study Venous Blood Study evaluated five distinct epigenetic clocks—Horvath, Hannum, PhenoAge, GrimAge, and DunedinPACE—to understand why these tools capture different aspects of physiological aging and how gene-expression scores might refine their interpretation.

Divergent Molecular Signatures Across Five Major Clocks

According to the study published in npj Aging, the five widely used epigenetic clocks reveal substantial differences in the molecular signatures they represent. Investigators evaluated data from 3,227 participants who had both DNA methylation and RNA-seq data available, dividing the sample into a training set and a hold-out test set. The number of differentially expressed genes associated with each clock varied widely, ranging from 49 for the Horvath clock to 3,204 for the DunedinPACE clock.

The findings indicate that larger clocks do not necessarily capture more gene expression changes. No differentially expressed genes were shared across all five clocks, and DunedinPACE exhibited the highest proportion of unique genes. The greatest overlap in gene expression occurred among second- and third-generation clocks, specifically GrimAge, PhenoAge, and DunedinPACE.

Biological Pathways and Immune System Involvement

The biological pathways linked to each clock also differed markedly. According to the research, DunedinPACE associated with the highest number of pathways, while the Horvath clock associated with the fewest. Although no single Reactome biological pathway appeared across all five tools, researchers identified several shared immune-related pathways. Hannum, PhenoAge, GrimAge, and DunedinPACE all shared pathways involving neutrophil degranulation, innate immune system signaling, and general immune system signaling, along with subset pathways linked to antimicrobial actions.

To evaluate these findings further, the investigators developed transcriptomic aging gene scores derived from the differentially expressed genes. They assessed how these scores related to epigenetic age acceleration measures and aging-related health outcomes, testing their transferability across external datasets.

Broader Context in Gerontological Research

Epigenetic modifications involve chemical changes to DNA or chromatin that influence gene expression without altering the underlying DNA sequence, according to background data from PMC. Age-related methylation sites comprise approximately 28% of the human genome, shifting in predictable ways that exhibit clock-like behavior. While traditional biomarkers offer only partial perspectives on aging, comparative studies consistently identify epigenetic clocks as the most promising tools for estimating biological age and evaluating anti-aging interventions.

Despite significant progress over the past decade in establishing epigenetic clocks as reliable aging biomarkers, substantial challenges remain. Researchers emphasize the ongoing need for robust, precise, and context-specific models tailored to specific age-related diseases and the primary drivers of biological aging.